Aim of the study was to evaluate a hybrid liver support system in a porcine model of acute liver failure, after hepatectomy. Pigs with a body weight of 70±18 kg underwent total hepatectomy and porto - cavo - caval shunting as well as ligation of the bile duct and the hepatic artery. Control animals were connected to the system (including capillary membrane plasma separation) containing a four compartment bioreactor with integral oxygenation and decentralized mass exchange but without liver cells. The treatment group received hybrid liver support with the same system including 370±42 g primary isolated porcine parenchymal liver cells in co-culture with hepatocyte nursing cells, tissue engineered to liver- like structures at high density. Treatment started after complete recovery from anesthesia and was performed continuously. A positive influence on peripheral vascular resistance and a reduced need of catecholamine dosage was observed in the treatment group. Hybrid liver support with a cell module upscaled for clinical application significantly prolonged survival time in animals after hepatectomy with the longest survival being 26 hours in the control group an 57 hours in the treatment group.
TakahashiM., MatsueH., MatsushitaM.Does a porcine hepatocyte hybrid artificial liver prolong the survival time of anhepatic rabbits?ASAIO J1992; 38: 468–72.
2.
SussmanN.L., ChongM.G., KoussayerT.Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology1992; 16: 60–65.
JaureguiH.O., HullonCJ-P, TrenklerD., NaikS.In vivo evaluation of a hollow fiber liver assist device. Hepatology1995; 21: 460–9.
6.
FlendrigL.M., ChamuleauRAFM, MaasM.A.W.Evaluation of a novel design bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection as a first attempt to monitor hepatocyte viability. Hepatology1999; 30: 311–20.
7.
FlendrigL.M., CaliseF., Di FlorioE.Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs1999; 22: 701–8.
8.
GerlachJ., TrostT., RyanC.J.Hybrid liver support system in a short term application on hepatectomized pigs. Int J Artif Organs1994; 17: 549–53.
9.
GerlachJ., JörresA., TrostO.Side effects of hybrid liver support therapy: TNF-α liberation in pigs, associated with extracorporeal bioreactors. Int J Artif Organs1993; 16: 604–8.
10.
GerlachJ., EnckeJ., HoleO., MüllerC., CourtneyJ., NeuhausP.. Hepatocyte culture between three dimensional arranged biomatrix- coated independent artificial capillary systems and sinusoidal endothelial cell co-culture compartments. Int J Artif Organs1994; 17: 301–6.
11.
JankeJ., GerlachJ., KardassisD.Effect of a hybrid liver support system on cardiopulmonary function in healthy pigs. Int J Artif Organs1997, 20: 570–5.
12.
GerlachJ., BrombacherJ., SmithM., NeuhausP.. High yield hepatocyte isolation from pig livers for investigation of hybrid liver support systems: Influence of collagenase concentration and body weight. J Surg Res1996; 62: 85–9.
13.
GerlachJ., BrombacherJ., KlöppelK., SmithM., SchnoyN., NeuhausP.. Comparison of four methods for mass hepatocyte isolation from pig and human livers. Transplantation1994; 57: 1318–22.
14.
GerlachJ., NeuhausP.. Culture model for primary hepatocytes. In vitro Cell Dev Biol1994; 30A: 640–2.
15.
GerlachJ., EnckeJ., HoleO., MüllerC., RyanC.J., NeuhausP.. Bioreactor for larger scale hepatocyte in vitro perfusion. Transplantation1994; 58: 984–8.
16.
GerlachJ., FuchsM., SmithM., BornemannR., NeuhausP., RiedelE.. Is a clinical application of hybrid liver support systems limited by an initial disorder in cellular amino acid and a-keto acid metabolism, rather than by later gradual loss of primary hepatocyte function?Transplantation1996; 62: 224–8.
17.
GerlachJ., SchnoyN., EnckeJ., MüllerC., SmithM., NeuhausP.. Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems: electron microscopy studies. Hepatology1995; 22: 546–52.
18.
GerlachJ.. Development of a hybrid liver support system - a review. Int J Artif Organs1996; 19: 645–55.
19.
JankeJ., GerlachJ., KardassisD.Effect of a hybrid liver support system on cardiopulmonary function in healthy pigs. Int J Artif Organs1997, 20: 570–5.
20.
GerlachJ., TrostT., RyanC.J.Hybrid liver support system in a short term application on hepatectomized pigs. Int J Artif Organs1994; 17: 549–53.
21.
IjimaH., NakazawaK., KanekoM.Preclinical animal experiment of a hybrid artificial liver. ASAIO J1999; 45: 201.
22.
TönnesenK.. Experimental liver failure. A comparison between hepatectomy and hepatic devascularisation in the pig. Acta Chir Scand1977; 143: 271–7.
23.
MazziottiA., BernardiM., AntoniniL.Plasma amino acid patterns in experimental acute hepatic failure: Comparison between hepatectomy and liver devascularization in pigs. Surgery1981; 90: 527–4.
UchinoJ., TsuburayaT., KumagaiF.A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. Trans Am Soc Artif Intern Organs1988; 34: 972–7.
26.
RozgaJ., WilliamsF., RoM.S.Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology1993; 17: 258–65.
SheilA.G.R., SunJ., MearsD.C.Preclinical trial of a bioartificial liver support system in a porcine fulminant heatic failure model. Aust NZ J Surg1996; 66: 547–52.
29.
GerlachJ.C., LemmensP., SchönM.Experimental evaluation of a hybrid liver support system. Transplant Proc1997; 29: 852.
30.
NaruseK., NagashimaI., SakaiY.Efficacy of a bioreactor filled with porcine hepatocytes immobilized on nonwoven fabric for ex vivo direct hemoperfusion treatment of liver failure in pigs. Int J Artif Organs1998; 22: 1031–7.
31.
IjimaH., NakazawaK., KanekoM.Preclinical animal experiment of a hybrid artificial liver. ASAIO J1999; 45: 201.
32.
FlendrigL.M., CaliseF., Di FlorioE.Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs1999; 22: 701–8.
33.
WatanabeF.D., MullonCJ-P, HewittW.R.Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical trial. Ann Surg1997; 225: 484–94.
34.
KardassisD., BusseB., KraemerM.R., SmithM.D., NeuhausP., GerlachJ.C.. Hemodynamic effects of therapy with a hybrid liver support system. ASAIO J1999; 45: 203.
35.
GerlachJ.. Development of a hybrid liver support system: a review. Int J Artif Organs1996; 11: 645–54.
36.
PatzerJ.F.II, MazariegosG.V., KramerD.J.Novel bioartificial liver support system (BLSS): Clinical experience. Int J Artif Organs1999; 22: 407.
